BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21321153)

  • 41. sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair.
    Alfaro MP; Vincent A; Saraswati S; Thorne CA; Hong CC; Lee E; Young PP
    J Biol Chem; 2010 Nov; 285(46):35645-53. PubMed ID: 20826809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative stress-induced Notch1 signaling promotes cardiogenic gene expression in mesenchymal stem cells.
    Boopathy AV; Pendergrass KD; Che PL; Yoon YS; Davis ME
    Stem Cell Res Ther; 2013 Apr; 4(2):43. PubMed ID: 23597145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous bone-marrow-derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model.
    Fukuhara S; Tomita S; Nakatani T; Yutani C; Kitamura S
    J Heart Lung Transplant; 2005 Jan; 24(1):67-72. PubMed ID: 15653382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.
    Li TS; Cheng K; Malliaras K; Smith RR; Zhang Y; Sun B; Matsushita N; Blusztajn A; Terrovitis J; Kusuoka H; Marbán L; Marbán E
    J Am Coll Cardiol; 2012 Mar; 59(10):942-53. PubMed ID: 22381431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
    Lu D; Liao Y; Zhu SH; Chen QC; Xie DM; Liao JJ; Feng X; Jiang MH; He W
    Stem Cell Res Ther; 2019 Apr; 10(1):127. PubMed ID: 31029167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD51 distinguishes a subpopulation of bone marrow mesenchymal stem cells with distinct migratory potential: a novel cell-based strategy to treat acute myocardial infarction in mice.
    Xie DM; Li YL; Li J; Li Q; Lu G; Zhai Y; Zhang J; Huang Z; Gao X
    Stem Cell Res Ther; 2019 Nov; 10(1):331. PubMed ID: 31747966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway.
    Lin M; Liu X; Zheng H; Huang X; Wu Y; Huang A; Zhu H; Hu Y; Mai W; Huang Y
    Stem Cell Res Ther; 2020 Jan; 11(1):22. PubMed ID: 31918758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction.
    Jujo K; Hamada H; Iwakura A; Thorne T; Sekiguchi H; Clarke T; Ito A; Misener S; Tanaka T; Klyachko E; Kobayashi K; Tongers J; Roncalli J; Tsurumi Y; Hagiwara N; Losordo DW
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11008-13. PubMed ID: 20534467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice: effects on transplanted cell survival and autologous endothelial progenitor cell mobilization.
    Cheng Y; Hu R; Lv L; Ling L; Jiang S
    J Surg Res; 2012 Jul; 176(1):e47-55. PubMed ID: 22595018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.
    Zhang M; Mal N; Kiedrowski M; Chacko M; Askari AT; Popovic ZB; Koc ON; Penn MS
    FASEB J; 2007 Oct; 21(12):3197-207. PubMed ID: 17496162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions.
    Wei HM; Wong P; Hsu LF; Shim W
    Singapore Med J; 2009 Oct; 50(10):935-42. PubMed ID: 19907881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart.
    Buccini S; Haider KH; Ahmed RP; Jiang S; Ashraf M
    Basic Res Cardiol; 2012 Nov; 107(6):301. PubMed ID: 23076626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mesenchymal stem cell-derived extracellular vesicles alone or in conjunction with a SDKP-conjugated self-assembling peptide improve a rat model of myocardial infarction.
    Firoozi S; Pahlavan S; Ghanian MH; Rabbani S; Barekat M; Nazari A; Pakzad M; Shekari F; Hassani SN; Moslem F; Lahrood FN; Soleimani M; Baharvand H
    Biochem Biophys Res Commun; 2020 Apr; 524(4):903-909. PubMed ID: 32057366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemin pre-treatment augments the cardiac protection of mesenchymal stem cells by inhibiting mitochondrial fission and improving survival.
    Deng R; Liu Y; He H; Zhang H; Zhao C; Cui Z; Hong Y; Li X; Lin F; Yuan D; Liang X; Zhang Y
    J Cell Mol Med; 2020 Jan; 24(1):431-440. PubMed ID: 31660694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source.
    Zhang S; Ge J; Sun A; Xu D; Qian J; Lin J; Zhao Y; Hu H; Li Y; Wang K; Zou Y
    J Cell Biochem; 2006 Nov; 99(4):1132-47. PubMed ID: 16795039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial Infarction.
    Lu W; Xie Z; Tang Y; Bai L; Yao Y; Fu C; Ma G
    Theranostics; 2015; 5(10):1068-82. PubMed ID: 26199646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reconstitution of aged bone marrow with young cells repopulates cardiac-resident bone marrow-derived progenitor cells and prevents cardiac dysfunction after a myocardial infarction.
    Li SH; Sun Z; Brunt KR; Shi X; Chen MS; Weisel RD; Li RK
    Eur Heart J; 2013 Apr; 34(15):1157-67. PubMed ID: 22507976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.